-
September 13, 2011
IUDs almost halve risk of cervical cancer: study
LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of an international study.
-
August 19, 2011
REFILE: Doctors screen for cervical cancer too often: study
NEW YORK (Reuters Health) - Most doctors opt for screening women for cervical cancer more often than guidelines suggest, according to a new study.
-
August 17, 2011
Doctors screen for cervical cancer too often: study
NEW YORK (Reuters Health) - Most doctors opt for screening women for cervical cancer more often than guidelines suggest, according to a new study.
-
April 25, 2011
Cervical cancer vaccines, tests donated to Rwanda
LONDON (Reuters) - U.S. drugmaker Merck and German diagnostics firm Qiagen are donating millions of human papillomavirus (HPV) vaccines and 250,000 HPV tests to Rwanda to start a national cervical cancer prevention program.
-
October 18, 2010
Eight virus types cause almost all cervical cancer
LONDON (Reuters) - Scientists have identified the eight human papillomavirus (HPV) types responsible for more than 90 percent of cervical cancer cases worldwide and say they should be the targets for the next generation of vaccines.
-
November 13, 2009
Cervical cancer vaccine hope for African women
DAR ES SALAAM (Reuters) - So crammed is Tanzania's only cancer treatment centre that Rukia Kondogoza, wrapped in bright kanga cloth, has to share her bed with another patient.
-
October 1, 2009
Cancer not cervical cancer vaccine killed UK teen
LONDON (Reuters) - The teenage girl who died shortly after being immunised against cervical cancer was killed by a malignant chest tumour and not by a reaction to the vaccine manufactured by GlaxoSmithKline, an inquest heard on Thursday.
-
September 29, 2009
Girl dies after receiving cervical cancer vaccine
LONDON (Reuters) - A teenage British girl died after receiving a cervical cancer vaccine made by GlaxoSmithKline, health officials said on Monday.
-
September 21, 2009
Minorities may shun cervical cancer vaccine
NEW YORK (Reuters Health) - Strong cultural beliefs and limited awareness may lead mothers from certain ethnic groups to choose not to have their daughters vaccinated against human papillomavirus (HPV), the virus responsible for most cases of cervical cancer, according to a study conducted in the UK.
-
September 9, 2009
US FDA panel backs Glaxo cervical cancer vaccine
GAITHERSBURG, Md.(Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday.
-
June 2, 2009
Cervical cancer vaccine benefits older women: study
WASHINGTON (Reuters) - Older women can benefit just as much as younger women from Merck's Gardasil vaccine against cervical cancer, researchers in Colombia reported on Monday.
-
April 3, 2009
Singapore questions cervical cancer vaccine for teens
SINGAPORE (Reuters) - A Singapore government minister questioned on Friday the effectiveness of cervical cancer vaccination for teenagers and said such prevention sends out a message that teenage sex is condoned by the community.
-
April 2, 2009
Qiagen virus test cuts deaths from cervical cancer
BOSTON (Reuters) - A single test that looks for the virus that causes cervical cancer cut the death rate from the tumor in half, researchers in India reported on Wednesday.
-
December 18, 2008
Male circumcision lowers cervical cancer risk: study
WASHINGTON (Reuters) - Three studies published on Wednesday add to evidence that circumcision can protect men from the deadly AIDS virus and the sexually transmitted virus that causes cervical cancer.
-
December 3, 2008
Cervical cancer chemo easier on black women: study
NEW YORK (Reuters Health) - Black women with advanced and recurrent cervical cancer tolerate "platinum-based" chemotherapy drugs better than do their white counterparts, according to a pooled data from three studies, researchers report.
-
November 13, 2008
Cervical cancer vaccine can protect men from HPV
WASHINGTON (Reuters) - A vaccine designed to protect women and girls from cervical cancer caused by a virus that also causes genital warts may protect men, too, maker Merck and Co reported on Thursday.
-
October 27, 2008
Aggressive vaccine effort could cut cervical cancer
CHICAGO (Reuters) - An aggressive strategy of vaccinating older women against cervical cancer could deliver a crippling blow against the disease, cutting rates for that type of cancer in half for women through age 45, U.S. researchers said on Saturday.
-
October 22, 2008
Few adverse reactions to cervical cancer vaccine
WASHINGTON (Reuters) - Girls and young women given Merck and Co's Gardasil vaccine to prevent cervical cancer were not any more likely than usual to faint, have an allergic reaction, blood clot, or other adverse reaction, federal officials said on Wednesday.
-
September 22, 2008
New test may stop cervical cancer in rural women
HONG KONG (Reuters) - A new rapid test for the human papillomavirus (HPV), which can cause cervical cancer, has proven to be 90 percent accurate in a trial involving women in rural villages in eastern China.
-
September 9, 2008
New cervical cancer test beats Pap smear
LONDON (Reuters) - A new way to test for cervical cancer is more accurate than a Pap smear and identified more dangerous lesions, an Italian study showed on Tuesday.
-
August 28, 2008
Cervical cancer advances give hope to poor
LONDON (Reuters) - New screening tests and effective vaccines from Merck & Co and GlaxoSmithKline make tackling cervical cancer in poor countries a real possibility for the first time, researchers said on Thursday.
-
August 19, 2008
Jade Goody has cervical cancer
LONDON (Reuters) - "Celebrity Big Brother" star Jade Goody has been diagnosed with cervical cancer, her spokesman said on Tuesday.
-
June 18, 2008
UPDATE 1-Britain picks Glaxo cervical cancer vaccine
LONDON (Reuters) - Britain's Department of Health has picked GlaxoSmithKline's cervical cancer vaccine Cervarix over Merck's Gardasil for its immunisation programme, Glaxo said on Wednesday.
-
May 14, 2008
Glaxo says cervical cancer vaccine works for longer
LONDON (Reuters) - GlaxoSmithKline said on Wednesday new data showed its Cervarix vaccine generated sustained, high levels of neutralizing antibodies against the two most common cervical cancer-causing virus types for 6.4 years.
-
May 7, 2008
Phone counseling helpful after cervical cancer
NEW YORK (Reuters Health) - Telephone counseling may give cervical cancer survivors a boost to their well-being, and possibly their immune function as well, a small study suggests.
-
April 29, 2008
Screening delay tied to advanced cervical cancer
NEW YORK (Reuters Health) - Not having had a Pap smear taken within the recommended screening interval was the most important risk factor for advanced cervical cancer observed during an audit of Sweden's cervical cancer screening program.
-
March 25, 2008
HPV test sensitive for cervical cancer detection
NEW YORK (Reuters Health) - Testing for human papillomavirus (HPV), the cause of most cervical cancers, is more sensitive than the results of conventional cervical tissue analysis, or Pap test, for the detection of cancer, according to the results of an Italian study published in the Journal of the National Cancer Institute. However, this is limited by the fact that HPV infections often resolve among women younger than 35 years of age.
-
February 7, 2008
More trial data backs Merck's cervical cancer shot
LONDON (Reuters) - New data from a combined analysis of four Phase II/III studies involving more than 20,000 women confirm the effectiveness of Merck & Co Inc's cervical cancer vaccine Gardasil, researchers said on Thursday.
-
January 24, 2008
Sexual problems persist after cervical cancer
NEW YORK (Reuters Health) - Women who beat cervical cancer may continue to have sexual difficulties and other problems that diminish their quality of life, a study shows.
-
January 22, 2008
Cervical cancer vaccine cost-effective: EU agency
LONDON (Reuters) - The vaccine against the sexually transmitted virus that causes the most cases of cervical cancer is cost-effective and should be given to adolescent girls before they start having sex, an EU agency said on Tuesday.
-
December 17, 2007
FDA has questions on Glaxo cervical cancer vaccine
LONDON (Reuters) - GlaxoSmithKline Plc's cervical cancer vaccine Cervarix faces a delay in winning approval in the United States, putting it further behind Merck & Co Inc's rival product Gardasil, which is already available.
-
November 9, 2007
Cervical cancer risk higher in women on the pill
CHICAGO (Reuters) - Women who take oral contraceptives run a higher risk of developing cervical cancer, but this risk is transient and reverts to normal about 10 years after they stop, British researchers said on Thursday.
-
November 6, 2007
Cervical cancer underestimated in Asia: expert
HONG KONG (Reuters) - Cervical cancer is much more common in Asia than the quarter of a million new cases recorded each year, according to an expert, who says governments should consider vaccinating all women because screenings are too costly.
-
October 31, 2007
Cervical cancer survivors prone to other cancers
NEW YORK (Reuters Health) - Women who survive cervical cancer are at increased risk for developing other cancers decades later, according to a report in the Journal of the National Cancer Institute. The increased cancer risk is primarily seen in women who were treated with radiation therapy and involves organs that lie near the cervix.
-
October 26, 2007
All girls aged 12 to 13 to get cervical cancer jabs
LONDON (Reuters Life!) - All girls aged 12 to 13 in England will be vaccinated against the sexually transmitted virus that causes most cervical cancer cases, the government said Friday.
-
October 26, 2007
Some women at long-term cervical cancer risk
LONDON (Reuters) - Women treated for pre-cancerous lesions are at increased risk of developing cervical or vaginal cancer for at least another 25 years, according to a study suggesting that follow-up tests fall dangerously short.
-
June 28, 2007
Benefits of cervical cancer vaccine confirmed
LONDON (Reuters) - The experimental cervical cancer vaccine, Cervarix, is 90 percent effective in preventing precancerous viral infection for most cases of cervical cancer. GlaxoSmithKline Plc reported in the Lancet.
-
June 20, 2007
UK experts back use of cervical cancer vaccine
LONDON (Reuters) - British medical experts have recommended that girls aged 12 to 13 should be vaccinated with Gardasil, the cervical cancer shot marketed by Merck & Co Inc and Sanofi-Aventis SA in Europe.
-
June 18, 2007
Swiss back cervical cancer shot, UK decision soon
LONDON (Reuters) - Switzerland has recommended that girls should be vaccinated with Gardasil, the cervical cancer shot marketed by Merck & Co Inc and Sanofi-Aventis SA in Europe, the firms said on Monday.
-
April 17, 2007
Cervical cancer vaccine protective for 5.5 years
LONDON (Reuters) - Cervarix, a vaccine designed to protect women against infection with human papillomavirus (HPV) type 16 and 18, which cause most cases of cervical cancer, remains effective for up to 5.5, according to researchers.
-
March 23, 2007
Merck says US CDC endorses cervical cancer vaccine
NEW YORK (Reuters) - Merck & Co. Thursday said the U.S. Centers for Disease Control and Prevention has adopted the recommendation of an advisory panel that the drugmaker's vaccine against cervical cancer routinely be given to females aged 11 through 26.